Search details
1.
Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infection.
Scand J Immunol
; 95(3): e13128, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34923667
2.
Targeting Influenza Virus Hemagglutinin to Xcr1+ Dendritic Cells in the Absence of Receptor-Mediated Endocytosis Enhances Protective Antibody Responses.
J Immunol
; 198(7): 2785-2795, 2017 04 01.
Article
in English
| MEDLINE | ID: mdl-28228559
3.
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation.
Leukemia
; 37(10): 2107-2114, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37568010
4.
Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection.
Front Immunol
; 13: 752714, 2022.
Article
in English
| MEDLINE | ID: mdl-35296089
5.
Author Correction: Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site.
Sci Rep
; 10(1): 5944, 2020 Mar 31.
Article
in English
| MEDLINE | ID: mdl-32231213
6.
Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site.
Sci Rep
; 9(1): 1820, 2019 02 12.
Article
in English
| MEDLINE | ID: mdl-30755656
7.
Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali.
Malar J
; 7: 175, 2008 Sep 15.
Article
in English
| MEDLINE | ID: mdl-18793404
Results
1 -
7
de 7
1
Next >
>>